Literature DB >> 10408296

Infectious complications of combination anticancer chemotherapy for urogenital cancers.

T Matsumoto1, K Takahashi, M Tanaka, J Kumazawa.   

Abstract

We reviewed the infectious complications in 207 courses of anticancer chemotherapy to 93 patients with urogenital cancer. Thirty episodes (14.5%) of neutropenic fever containing 9 cases (4.3%) of infection were observed. Five patients (16.7%) had pyelonephritis, one (3.3%) had acute prostatitis, two (6.6%) had pneumonia and one (3.3%) had bacteraemia. Multivariate analysis revealed that the infectious complications during anticancer chemotherapy were mainly associated with urinary diversion, hydronephrosis and duration of severe neutropenia (<500/mm3). These results suggest that infectious complications should be prevented in patients with urinary diversion, hydronephrosis and severe neutropenia during anticancer chemotherapy for urogenital cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10408296     DOI: 10.1023/a:1007107403610

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  Growth factors and empiric therapy with antibiotics: should they be used concurrently?

Authors:  S C Schimpff
Journal:  Ann Intern Med       Date:  1994-10-01       Impact factor: 25.391

2.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

3.  Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. Kyushu University Urological and Radiological Oncology Group.

Authors:  S Naito; T Kuroiwa; T Ueda; K Hasuo; K Masuda; J Kumazawa
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

Review 4.  Empirical therapy for bacterial infections in neutropenic patients.

Authors:  J Klastersky
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

5.  [Infection in genitourinary cancer patients during cancer chemotherapy].

Authors:  Y Ito; H Komeda; A Saitoh; T Deguchi; Y Ban; Y Kawada
Journal:  Hinyokika Kiyo       Date:  1994-03

6.  Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy.

Authors:  J P Sculier; D Weerts; J Klastersky
Journal:  Eur J Cancer Clin Oncol       Date:  1984-01

7.  Empirical antibiotic therapy for fever in neutropenic patients.

Authors:  G P Bodey
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

Review 8.  Management of the cancer patient with fever and prolonged neutropenia.

Authors:  J W Lee; P A Pizzo
Journal:  Hematol Oncol Clin North Am       Date:  1993-10       Impact factor: 3.722

Review 9.  Infections in cancer patients: some controversial issues.

Authors:  S C Schimpff; D A Scott; J C Wade
Journal:  Support Care Cancer       Date:  1994-03       Impact factor: 3.603

10.  Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.

Authors:  D W Maher; G J Lieschke; M Green; J Bishop; R Stuart-Harris; M Wolf; W P Sheridan; R F Kefford; J Cebon; I Olver; J McKendrick; G Toner; K Bradstock; M Lieschke; S Cruickshank; D K Tomita; E W Hoffman; R M Fox; G Morstyn
Journal:  Ann Intern Med       Date:  1994-10-01       Impact factor: 25.391

View more
  1 in total

1.  Clinical analysis of febrile neutropenia in urological anticancer chemotherapy: retrospective single center study.

Authors:  Naotaka Nishiyama; Satoshi Takahashi; Takahiro Mizuno; Teruhisa Uehara; Jiro Hashimoto; Yuichirou Kurimura; Naoya Masumori
Journal:  Int J Clin Oncol       Date:  2015-02-05       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.